Quebec-based Valeant Pharmaceuticals International cut all ties with Philidor Rx Services. This comes in the wake of recent revelations that Valeant was looking to acquire Philidor, a relationship that raised questions from various quarters. Valeant is the subject of U.S. federal investigations.